Director, Market Access (Rare Diseases)

At Regeneron, we are committed to redefining healthcare. Join our mission to ensure patients across Europe have access to life‑changing therapies. As the Regional Access Lead for Rare Diseases (Europe Region), you will play a pivotal role in driving market access, pricing, and reimbursement strategies for our innovative portfolio of rare disease treatments.

This is an outstanding opportunity to develop healthcare policy, engage with key partners, and make a tangible impact on patients’ lives. Collaborating with global, regional, and local teams, you will lead initiatives that align with EU‑wide healthcare systems and payer requirements, ensuring our therapies reach those who need them most.

In a typical day you will:

• Develop and implement comprehensive strategies tailored to rare diseases in the EU region, ensuring alignment with global and local objectives.
• Supervise EU healthcare policies, payer trends, and reimbursement frameworks to find opportunities and address challenges.
• Collaborate with cross‑functional teams, including commercial, medical affairs, and HEOR, to ensure cohesive strategy execution.
• Adapt global market access tools to meet regional requirements and maintain consistency in product value propositions.
• Own the preparation and submission of HTA dossiers across EU countries, employing evidence‑based approaches to secure reimbursement.
• Build and maintain positive relationships with payers, policymakers, and patient advocacy groups to drive access initiatives.
• Partner with medical affairs and in‑country teams to align evidence generation plans with EU payer requirements.
• Coordinate advisory boards, conduct market research, and perform landscape assessments to advise strategic decisions.

This role might be for you if you:

• Are passionate about improving access to innovative therapies for rare diseases.
• Have a proven track record in pricing, reimbursement, and market access strategies across multiple EU countries.
• Excel at establishing relationships with diverse collaborators, including payers, policymakers, and patient advocacy groups.
• Are skilled at navigating the complexities of EU healthcare systems and reimbursement frameworks.
• Thrive in a collaborative, matrixed environment and can align cross‑functional teams to achieve shared goals.
• Have strong analytical skills and can synthesize sophisticated data into actionable insights.
• Are fluent in English, with additional European languages being a plus.

To Be Considered:

You must have a minimum of 10 years of experience in the pharmaceutical industry, with at least 8 years in market access roles. An advanced degree in Life Sciences, Health Economics, or Business is preferred (master’s or PhD desirable).

The ideal candidate will have demonstrated success in HTA submissions, pricing negotiations, and reimbursement approval processes in Europe, with experience leading rare disease product launches. Familiarity with EU healthcare policy shaping and multi‑stakeholder engagement is a strong advantage.

Join us in driving access to life-changing therapies. Together, we can make a difference.

Apply today to be part of our mission.

Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We have an inclusive culture that provides comprehensive benefits, which vary by location.

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or parental status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. The Company will also provide reasonable accommodation to the known disabilities or chronic illnesses of an otherwise qualified applicant for employment, unless the accommodation would impose undue hardship on the operation of the Company’s business.

#J-18808-Ljbffr